U.S. flag

An official website of the United States government

Here’s how you know
Here’s how you know

**Official websites use .gov**
A **.gov** website belongs to an official government organization in the United States.

**Secure .gov websites use HTTPS**
A **lock** ( A locked padlock) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Search Query:
			MAIN MENU

																				
              Health Topics
								All Health Topics A-Z
					
													
		

		Asthma


				

															Heart-Healthy Living


				

															High Blood Pressure


				

															Sickle Cell Disease


				

															Sleep Apnea


				

															Information & Resources on COVID-19
																				
              Health Education
								Education Programs and Initiatives
					
													
		

		The Heart Truth®


				

															Learn More Breathe Better®


				

															Blood Diseases and Disorders Education Program


				

															Publications and Resources
																				
              The Science
								Research Focus Areas
					
													
		

		Blood Disorders and Blood Safety


				

															Sleep Science and Sleep Disorders


				

															Lung Diseases


				

															Health Disparities and Inequities


				

															Heart and Vascular Diseases


				

															Precision Medicine Activities


				

															Obesity, Nutrition, and Physical Activity


				

															Population and Epidemiology Studies


				

															Women’s Health


				

															Research Topics


				

															Clinical Trials


				

															All Science A-Z
																				
              Grants and Training
								Grants and Training Home


				

															Policies and Guidelines


				

															Funding Opportunities and Contacts


				

															Training and Career Development
																				
              News and Events
								News and Events Home
					
													
		

		Email Alerts


				

															All News
					
													
		

		NHLBI News


				

															NHLBI in the Press


				

															Research Features


				

															All Events
					
													
		

		Past Events


				

															Upcoming Events
																				
              About NHLBI
								About NHLBI Home
					
													
		

		Mission and Strategic Vision


				

															Leadership


				

															Divisions, Offices and Centers


				

															Advisory Committees


				

															Budget and Legislative Information


				

															Jobs and Working at the NHLBI


				

															Contact and FAQs


				

															NIH Sleep Research Plan
						
						HOME
		Search Text: Home/< Back ToThe Science/Recipient Epidemiology and Donor Evaluation Study (REDS) Program

Recipient Epidemiology and Donor Evaluation Study (REDS) Program
                        
                                                Project began
            1989
              Point of contact
            
                
            Benyam Hailu M.D., M.P.H.
              Website
            
                
            https://redsivp.com/
                                        On this page
                        At a Glance
                                                                                                                    How does it contribute to scientific discovery?
                                                            How is the current program conducted?
                                                                                        Feature
                                                                                        Related Reading
        What is the goal of the REDS program?
                        
            The goal of the REDS program is to evaluate and improve the safety and availability of the blood supply, as well as the safety and effectiveness of transfusion therapies. The program also works to proactively address potential emerging threats to the nation’s blood supply and serves as a resource for ongoing work in transfusion research. Now in its fourth phase, the Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P) program aims primarily at improving the benefits of transfusion while reducing its risks; the REDS program also has a new focus on previously understudied populations.

Over the past 30 years, REDS has been the premier research program in blood collection and transfusion safety in the United States. In its third phase — REDS-III — the program focused on conducting research on all elements of the transfusion chain, from the blood donor to the blood products made from their donation to the adult patients receiving the products through transfusion. The program compiled the linked demographic, clinical, and laboratory data on blood donors and recipients into comprehensive databases that are available through NHLBI’s Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC).

REDS-IV-P builds on REDS-III with an additional focus on research with newborns, children, and pregnant women who need transfusions. The data compiled in REDS-IV-P will allow investigators to rapidly address key research questions in transfusion medicine and inform blood policy decisions, for adults as well as for children and other understudied patient populations.

REDS-IV-P also extends the Brazilian sickle cell disease cohort that was established in REDS-III to evaluate transfusion practices and associated clinical outcomes in sickle cell disease. The REDS-IV-P Brazilian transfusion program continues its monitoring and surveillance efforts for Zika, chikungunya, dengue, and other emerging viral threats to the blood supply.
                AT A GLANCE
                                        REDS protects the nation’s blood supply through research to improve blood component safety and availability and the safety and effectiveness of transfusions.
          The REDS program was launched by NHLBI in 1989 and has had three additional phases: REDS-II, REDS-III, and REDS-IV-P.
          Internationally, REDS seeks to reduce and prevent the transmission of HIV and infectious agents, such as dengue and Zika viruses, through blood transfusion.
          REDS-III began integrating adult transfusion recipient epidemiology and laboratory research to enhance the safety of transfusions.
          REDS-IV-P expands the work of REDS-III to include newborns, children, and pregnant women who receive transfusions in the United States.
            How does the REDS program contribute to scientific discovery?
    The program has established scientific approaches to assessing the risks of contracting transfusion-transmitted infectious agents, established databases to evaluate the blood supply and specific populations of transfused patients, and added shareable biorepository resources for the scientific community.
    More Information
      
	-
		Recipient Epidemiology and Donor Evaluation Study (REDS) Program
    Findings from the original REDS program, which was created in response to the emerging HIV/AIDS epidemic, dramatically improved blood safety. REDS-II approached both infectious and noninfectious problems, such as transfusion-related acute lung injury, that could affect the U.S. and international blood supply.

Key scientific contributions from REDS-III include:

Studies that informed public health policies, including one that established donor deferral periods for men who have sex with men
	Studies that helped better estimate the risk of HIV infection from transfusion, including the creation of standardized methods to calculate the risk of HIV infection and the evaluation of new tools to detect transfusion-transmitted infection in countries where tools for screening blood donations are not readily available
	A comprehensive research database that links information about blood donors, their donations, the blood products made from these donations, and transfusion recipients
	Strategies to reduce iron deficiency in donors
	Studies to improve red blood cell storage and identify which donors have red blood cells that are better for routine storage
	Studies to address emerging infectious disease threats, such as dengue and Zika viruses. These studies include:
	A U.S. natural history study of Zika virus resulting in the establishment of a shareable biorepository. The virus samples were shared with collaborating academic institutions and commercial assay developers, who are using the samples to study markers of the virus and the immune response. This information will help in the development of tests to diagnose Zika infection.
		A study conducted in Brazil to estimate the risk of dengue being transmitted by transfusion
	Studies to look at transfusion outcomes in certain patient populations, such as people in Brazil who have sickle cell disease and women in South Africa who have postpartum hemorrhage
              How is the REDS-IV-P program conducted?
    The U.S. component of the REDS-IV-P program has four research hubs. Each hub has a blood center and offers transfusion services to support health care and community hospitals. The international component involves collaborations between U.S. and Brazilian researchers. The research activities of all REDS-IV-P hubs are supported by a data coordinating center (Westat, Maryland) and a center for transfusion laboratory studies (Vitalant Research Institute, California).

The REDS-IV-P program serves as a resource to the scientific community by giving investigators outside the program opportunities to:

Collaborate with REDS-IV-P researchers
	Access biospecimens and scientific expertise
	Analyze data on transfusion and transfusion-associated outcomes in patient populations that are otherwise not available in the United StatesAnother important part of the collaborative research effort in REDS-IV-P is the training of junior investigators in blood banking and transfusion medicine research. This enables NHLBI to build research capacity in an area of tremendous global public health importance.
                FEATURE
                                        Photo of a a young patient receiving a blood transfusion.
                        Blood Donor Basics
                            Every two seconds, someone in the U.S. needs blood. And according to the American Red Cross, a single donation can save up to three lives.
                                                        
            Learn more.
                            Related Scientific Focus Areas
                                    Blood Disorders and Blood Safety
                                                                                                                                                                Related Health Topics
                                    What Is Anemia?
              Blood Tests
              Treatments for Blood Disorders
              Iron-Deficiency Anemia
              What Is Sickle Cell Disease?
              What Is Thalassemia? Back To Top Link
  

        

        Back to top
  Web Policies & Notices
  

        

              Accessibility
                      No FEAR Act Data
                      Privacy Policy
                      Freedom of Information Act (FOIA)
                      HHS Vulnerability Disclosure
    
          Related Government Websites
  

        

              Health and Human Services
                      National Institutes of Health
                      Office of the Inspector General
                      USA.gov
    
          Stay Connected
    
      
            chat bubblesLive ChatLive Chat with us, Monday through Friday, 8:30 a.m. to 5:00 p.m. EST.envelopeGet Email AlertsReceive automatic alerts about NHLBI related news and highlights from across the Institute.
  Footer Bottom
  

        



Contact Us
                            Site Index
                            Jobs